04-1666 Sigma-AldrichRabbit-Anti-Human IgG1 Antibody, clone RM117
This Rabbit-Anti-Human IgG1 Antibody, clone RM117 is validated for use in ELISA for the detection of Rabbit-Human IgG1.
More>> This Rabbit-Anti-Human IgG1 Antibody, clone RM117 is validated for use in ELISA for the detection of Rabbit-Human IgG1. Less<<Prodotti consigliati
Panoramica
Replacement Information |
---|
Tabella delle specifiche principali
Species Reactivity | Key Applications | Host | Format | Antibody Type |
---|---|---|---|---|
H | ELISA | Rb | Purified | Monoclonal Antibody |
Description | |
---|---|
Catalogue Number | 04-1666 |
Description | Rabbit-Anti-Human IgG1 Antibody, clone RM117 |
References |
---|
Product Information | |
---|---|
Format | Purified |
Presentation | Rabbit monoclonal in PBS with 1% BSA and 0.09% sodium azide. |
Quality Level | MQ300 |
Applications | |
---|---|
Application | This Rabbit-Anti-Human IgG1 Antibody, clone RM117 is validated for use in ELISA for the detection of Rabbit-Human IgG1. |
Key Applications |
|
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Packaging Information | |
---|---|
Material Size | 100 μg |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Numero di catalogo | GTIN |
04-1666 | 04055977181340 |
Documentation
Rabbit-Anti-Human IgG1 Antibody, clone RM117 MSDS
Titolo |
---|
Rabbit-Anti-Human IgG1 Antibody, clone RM117 Certificati d'Analisi
Titolo | Numero di lotto |
---|---|
Rabbit-Anti-Human IgG1, -QVP1504018 | QVP1504018 |
Rabbit-Anti-Human IgG1, clone RM117 - VP1903221 | VP1903221 |
Rabbit-Anti-Human IgG1, clone RM117 - VP2411137 | VP2411137 |
Rabbit-Anti-Human IgG1, clone RM117 Monoclonal Antibody | VP1708112 |
Informazioni tecniche
Titolo |
---|
Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
White Paper: Further considerations of antibody validation and usage. |